ORIC PHARMACEUTICALS INC COM

ORIC PHARMACEUTICALS INC COM is a security (CUSIP 68622P109) tracked across SEC portfolio filings. 179 institutional managers reported $1.4B on Form 13F as of 2026-06-30; 22 registered fund positions totaling $126.5M via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 179 managers by value.

ManagerLocationValueShares
Nextech Invest, Ltd.Zurich, V8$90.8M7,162,637
EcoR1 Capital, LLCSan Francisco, CA$85.2M6,728,116
BlackRock, Inc.New York, NY$75.8M5,984,552
VIKING GLOBAL INVESTORS LPSTAMFORD, CT$73.8M5,824,533
SR ONE CAPITAL MANAGEMENT, LPWAYNE, PA$58.5M4,514,929
Pfizer IncNew York, NY$57.7M4,780,401
ALKEON CAPITAL MANAGEMENT LLCNew York, NY$57.1M4,504,096
VR Adviser, LLCNEW YORK, NY$54.7M4,319,765
NEA Management Company, LLCTIMONIUM, MD$52.2M4,118,621
STATE STREET CORPBOSTON, MA$46.9M3,702,196
Column Group LLCSan Francisco, CA$44.9M3,540,777
Siren, L.L.C.New York, NY$38.0M2,998,192
VANGUARD GROUP INCValley Forge, PA$37.2M4,541,974
ORBIMED ADVISORS LLCNew York, NY$34.1M2,693,929
AIHC Capital Management LtdCENTRAL, K3$31.2M2,459,551

Top fund holders (N-PORT)

Showing 15 of 22 fund positions by value.

FundRegistrantValue% of fund
ACAP Strategic FundACAP Strategic Fund$28.2M27.25%
T. Rowe Price Health Sciences Fund, Inc.T. ROWE PRICE HEALTH SCIENCES FUND, INC.$22.1M20.24%
Advantage Advisers Xanthus Fund, L.L.C.Advantage Advisers Xanthus Fund, L.L.C.$16.4M55.26%
T. Rowe Price New Horizons Fund, Inc.T. ROWE PRICE NEW HORIZONS FUND, INC.$12.5M9.78%
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$10.9M1.34%
Meridian Contrarian FundMeridian Fund Inc$9.4M159.31%
Fidelity Growth Company FundFidelity Mt. Vernon Street Trust$6.1M0.61%
ROYCE SMALL-CAP TRUST, INC.ROYCE SMALL-CAP TRUST, INC.$4.8M21.69%
ROYCE MICRO-CAP TRUST, INC.ROYCE MICRO-CAP TRUST, INC.$4.3M63.11%
VANGUARD RUSSELL 2000 INDEX FUNDVANGUARD SCOTTSDALE FUNDS$2.9M1.64%
U.S. MICRO CAP PORTFOLIODFA INVESTMENT DIMENSIONS GROUP INC$2.8M3.71%
T. Rowe Price Health Sciences PortfolioT. ROWE PRICE EQUITY SERIES, INC.$1.4M21.12%
Master Small Cap Index SeriesQuantitative Master Series LLC$1.3M2.73%
BlackRock Health Sciences Term TrustBlackRock Health Sciences Term Trust$1.3M12.39%
VANGUARD BALANCED INDEX FUNDVANGUARD VALLEY FORGE FUNDS$625K0.11%

More